The short version of hGH fragment fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-12-28. Anything still debated is marked as such rather than presented as settled.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Derived from C-terminal region of human growth hormone |
| Approximate molecular mass | About 1.8 kDa | Varies with sequence length and counterions |
| Confirmed receptor target | None established | No confirmed growth hormone receptor agonism |
| Reported in vitro activity | Lipolysis stimulation and lipogenesis inhibition | Observed mainly in adipocyte models; human relevance uncertain |
| Regulatory status | Not approved as a drug in major markets | May be treated differently across jurisdictions; not a recognized dietary ingredient in some countries |
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
RuBP + O2 → Phosphoglycolate + 3-phosphoglycerate + 2 H+ During the catalysis by RuBisCO, an 'activated' intermediate is formed (an enediol intermediate) in the RuBisCO active site. This intermediate is able to react with either CO2 or O2. It has been demonstrated that the specific shape of the RuBisCO active site acts to encourage reactions with CO2. Although there is a significant "failure" rate (~25% of reactions are oxygenation rather than carboxylation), this represents significant favouring of CO2, when the relative abundance of the two gases is taken into account: in the current atmosphere, O2 is approximately 500 times more abundant, and in solution O2 is 25 times more abundant than CO2. The ability of RuBisCO to specify between the two gases is known as its selectivity factor (or Srel), and it varies between species, with angiosperms more efficient than other plants, but with little variation among the vascular plants. A suggested explanation of RuBisCO's inability to discriminate completely between CO2 and O2 is that it is an evolutionary relic: The early atmosphere in which primitive plants originated contained very little oxygen, the early evolution of RuBisCO was not influenced by its ability to discriminate between O2 and CO2.
Graphite oxides absorb moisture in proportion to humidity and swell in liquid water. The amount of water absorbed by graphite oxides depends on the particular synthesis method and shows a strong temperature dependence. Brodie graphite oxide selectively absorbs methanol from water/methanol mixtures in a certain range of methanol concentrations. Membranes prepared from graphite oxides (recently more often called "graphene oxide" membranes) are vacuum tight and impermeable to nitrogen and oxygen, but are permeable to water vapors. The membranes are also impermeable to "substances of lower molecular weight". Permeation of graphite and graphene oxide membranes by polar solvents is possible due to swelling of the graphite oxide structure. The membranes in swelled state are also permeable by gases, e.g. helium. Graphene oxide sheets are chemically reactive in liquid water, leading them to acquire a small negative charge. The interlayer distance of dried graphite oxides was reported as ~6–7 Å but in liquid water it increases up to 11–13 Å at room temperature. The lattice expansion becomes stronger at lower temperatures. The inter-layer distance in diluted NaOH reached infinity, resulting in dispersion of graphite oxide into single-layered graphene oxide sheets in solution. Graphite oxide can be used as a cation exchange membrane for materials such as KCl, HCl, CaCl2, MgCl2, BaCl2 solutions. The membranes were permeable by large alkali ions as they are able to penetrate between graphene oxide layers.
Broadly, aptamers are small molecules composed of either single-stranded DNA or RNA and are typically 20-100 nucleotides in length, or ~3-60 kDa. Because of their single-stranded nature, aptamers are capable of forming many secondary structures, including pseudoknots, stem loops, and bulges, through intra-strand base pairing interactions. The combinations of secondary structures present in an aptamer confer it a particular tertiary structure which in turn dictates the specific target the aptamer will selectively bind to. Because of the selective binding ability of aptamers, they are considered a promising biomolecule for use in pharmaceuticals. Additionally, aptamers exhibit tight binding to targets, with dissociation constants often in the pM to nM range. Besides their strong binding ability, aptamers are also valued because they can be used on targets that are not capable of being bound by small peptides generated by phage display or by antibodies, and they are able to differentiate between conformational isomers and amino acid substitutions. Also, because aptamers are nucleic-acid based, they can be directly synthesized, eliminating the need for cell-based expression and extraction as is the case in antibody production. RNA aptamers in particular are capable of producing a myriad of different structures, leading to speculations that they are more discriminating in their target affinity compared to DNA aptamers.
As an appendix to the novel, Stephenson includes three "Calca", discussions among the avout of purely philosophical or mathematical content. The first is a discussion of a cake-cutting procedure corresponding to the geometric problem of "doubling the square" presented in Plato's Meno. The second presents configuration spaces (called "Hemn spaces" in the novel) as a way of representing three-dimensional motion. The third discusses a "complex" Platonic realism, in which several realms of Platonic ideal forms (called the "Hylaean Theoric Worlds" in the novel) exist independently of the physical world (called the "Arbran Causal Domain" in the novel). The mathematical structure of a directed acyclic graph is used to describe the way in which the various realms can influence one other, and even the physical world can function as part of the realm of ideal forms for some worlds "downstream" in the graph.
January 3, 2013: Decree establishing an interministerial mission for the protection of women against violence and the fight against human trafficking. January 3, 2013: Decree establishing the High Council for Gender Equality. January 31, 2013: Law repealing Law No. 2010-1127 of September 28, 2010, aimed at combating school absenteeism. May 17, 2013: Law on the election of departmental, municipal, and community councillors and modifying the electoral calendar. May 17, 2013: Law opening marriage to same-sex couples. June 19, 2013: National interprofessional agreement "Toward a policy of improving quality of life at work and professional equality." July 8, 2013: Orientation and programming law for the refoundation of the Republic's school system. July 22, 2013: Law on higher education and research, notably requiring gender parity in elections and appointments to governance bodies of institutions. August 2, 2013: Law on the election of senators, introducing measures to increase female representation. August 5, 2013: Law on various adjustments in justice according to EU law and France's international commitments. November 2013: Fourth interministerial plan for preventing and combating violence against women. December 2013: Bill on combating the prostitution system. December 27, 2013: Decree on the annual report on professional equality in the civil service. January 20, 2014: Law ensuring the future and fairness of the pension system. April 16, 2014: Decree on the responsibilities of the Minister for Women's Rights, Cities, Youth, and Sports.
Sources: en.wikipedia.org
The Federal Prosecution Office by the Court of Accounts requested that the TCU investigate a possible irregularity in the use of public resources for the leisure trip. After the controversy, Macêdo replaced the ministry's executive secretary. Maria Coelho, then the secretary at the time, refused to authorize the use of public money for the out-of-season carnival trip, so the minister himself allegedly signed the authorization; thus, Maria resigned from the position under the argument of "differences with the head of the ministry". The new secretary is Kelli Mafort, former coordinator of the MST.
It contained an immense rectangular hall, 55 metres long, 25 wide, and 15 metres high, supported by forty slender cast-iron columns, and was originally covered with a glass roof one thousand square metres in size. The building suffered from technical problems, and was closed entirely in 1965. It was extensively remodelled between 1991 and 1994 and reopened in its present form. The great central hall, kept in its same form but enlarged during the modernisation, is devoted to the presentation of marine animals on the lower sides, and, on a platform in the centre, a parade of full-size African mammals, including a rhinoceros originally presented to King Louis XV in the 18th century. On the garden side is another hall, in its original size, devoted to animals which have disappeared or are in danger of extinction.
From the 17th century, and before modern developments in organic chemistry nomenclature, acetone was given many different names. They included "spirit of Saturn", which was given when it was thought to be a compound of lead and, later, "pyro-acetic spirit" and "pyro-acetic ester". Prior to the name "acetone" being coined by French chemists, it was named "mesit" (from the Greek μεσίτης, meaning mediator) by Carl Reichenbach, who also said that methyl alcohol consisted of mesit and ethyl alcohol. Names derived from mesit include mesitylene and mesityl oxide which were first synthesised from acetone. In 1839, the name "acetone" began to be used, because it was obtained from acetic acid. Unlike many compounds with the acet- prefix which have a 2-carbon chain, acetone has a 3-carbon chain. That has caused confusion because there can not be a ketone with 2 carbons. The prefix refers to acetone's relation to vinegar (acetum in Latin, also the source of the words "acid" and "acetic"), rather than its chemical structure.
== Oxygen-20 == Oxygen-20 has a half-life of 13.51±0.05 s and decays by β− decay to 20F. It is one of the known cluster decay ejected particles, being emitted in the decay of 228Th with a branching ratio of about (1.13±0.22)×10−13.
As a medication, insulin is any pharmaceutical preparation of the protein hormone insulin that is used to treat high blood glucose. Such conditions include type 1 diabetes, type 2 diabetes, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states. Insulin is also used along with glucose to treat hyperkalemia (high blood potassium levels). Typically it is given by injection under the skin, but some forms may also be used by injection into a vein or muscle. There are various types of insulin, suitable for various time spans. The types are often all called insulin in the broad sense, although in a more precise sense, insulin is identical to the naturally occurring molecule whereas insulin analogues have slightly different molecules that allow for modified time of action. It is on the World Health Organization's List of Essential Medicines. In 2023, it was the 157th most commonly prescribed medication in the United States, with more than 3 million prescriptions. Insulin can be made from the pancreas of pigs or cows. Human versions can be made either by modifying pig versions, or recombinant technology using mainly E. coli or Saccharomyces cerevisiae. It comes in three main types: short–acting (such as regular insulin), intermediate-acting (such as neutral protamine Hagedorn (NPH) insulin), and longer-acting (such as insulin glargine).
Sources: en.wikipedia.org
On 15 August 2008, Permskie Novosti reported that a Russian soldier had called home on 10 August and told his mother: "We are there [in South Ossetia] since 7 August. All of our 58th army." On 15 August 2008, Vyatksky krai reported that the sister of soldier Vitaly (who was fighting in South Ossetia) said that her brother called on 6 August and he was going to move [to unknown location]; later, Vitaly told his sister on 7 August that "we are going to the mountains." On 15 August 2008, Komsomolskaya Pravda reported that 19-year-old Onar Aliev from the 19th Motor Rifle Division died in South Ossetia on the night of 8 August during the shelling of Tskhinvali. His mother said her son called for the last time on 4 August and told her that he would participate in the "true exercises" somewhere near Abkhazia. On 15 August 2008, Trud made a report about junior sergeant Aleksandr Sviridov who was killed in South Ossetia. He called his mother on 2 August and said: "There won't be any holiday. There are intensified preparations; we frequently have parachute jumps. Apparently, we will be deployed to somewhere." On 17 August 2008, Komsomolskaya Pravda reported that Aleksandr Plotnikov, the soldier from 693rd Regiment, said that he knew in early August that there would be war when two companies of his regiment were sent to the mountains near Tskhinvali. In August 2008, Life.ru reported that 29-year Aleksey Tarasov, who was killed in action in South Ossetia, was buried in his village.
== Titanium dioxide and zinc oxide nanoparticles in sunscreen == Sunscreens are utilized to secure the skin from the destructive impacts of ultraviolet radiation from the sun. UVB (290-320 nm) together with UVA-2 (320–340 nm) and UVA-1 (340–400 nm) cause organic and metabolic reactions in the skin. Titanium dioxide (TiO2) and zinc oxide (ZnO) minerals are often utilized in sunscreens as inorganic physical sun blockers owing to their absorption of light in the UV range. As TiO2 is proven to be more effective for blocking UVB and ZnO in the UVA range, the mix of these particles guarantees a broad-band UV shield. To solve the cosmetic disadvantage of these opaque sunscreens, TiO2 and ZnO nanoparticles have been used as a replacement for TiO2 and ZnO microparticles. Since the surface area to volume proportion of particles increases as the particle measurement diminishes, nanoparticles (NPs), ie, nano objects with all dimensions in the nanoscale, might be increasingly (bio)reactive than typical mass materials. When particles become smaller than 100 nm, novel optical attributes develop, owing to discrete nature of nanoparticle optical energy levels. Pat et al., for instance, measured a 0.15 eV blue shift for 4.7 nm TiO2 nanoparticles relative to the bulk material counterpart. When particles become smaller than the ideal light dispersing size (roughly half of the wavelength) visible light is transmitted and the particles appear transparent. This phenomenon explains the cosmetically undesired opaqueness of inorganic sunscreens and makes the utilization of NPs monetarily appealing.
== See also == Americanization Anti-American sentiment American stereotypes Cocacolonization Cultural imperialism Debates over Americanization Military globalization McDonaldization Pax Americana Sovietization Sovietization of the Baltic states Soviet socialist patriotism United States in the 1950s
Debra Houry, Chief Medical Officer Demetre Daskalakis, Director of the National Center for Immunization and Respiratory Diseases Daniel Jernigan, Director of the National Center for Emerging and Zoonotic Infectious Diseases Jennifer Layden, Director of the Office of Public Health Data, Surveillance, and Technology, which contains the National Center for Health Statistics Dozens of CDC employees walked out of headquarters and protested in support of Monarez and the departing officials.
== Characterization == Th22 cells are mainly defined by their high secretion of interleukin-22 (IL-22). Besides IL-22, Th22 cells also produce other cytokines, such as interleukin-13 (IL-13) and tumor necrosis factor alpha (TNF-alpha), but in very small quantities. Additionally, they could be characterized by their cell surface expression of CD3, CD4, CD28, number of chemokine receptors CCR10, CCR6, CCR4 that are associated with cutaneous T cell homing, and platelet-derived growth factor receptor (PGDFR).
Sources: en.wikipedia.org
AOD9604 is a synthetic peptide based on a C-terminal segment of human growth hormone. It is manufactured by chemical peptide synthesis rather than extracted from human tissue. The sequence is often described as hGH fragment 176–191 or a close variant.
It is not approved as a prescription drug in the United States or the European Union for any indication. Regulatory status can differ by country, and it is often sold as a research chemical or in unapproved products. Such products are not equivalent to an approved medicine.
In the studies reported so far, AOD9604 does not appear to act through the growth hormone receptor and has not shown the typical IGF-1 increase caused by full-length hGH. Human data are limited, so this remains an area of uncertainty. It should not be assumed to have the same effects as hGH.
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.